BACKGROUND: Knowledge of adipose composition in relation to mortality may help delineate inconsistent relationships between obesity and mortality in old age. We evaluated relationships between abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) density, mortality, biomarkers, and characteristics. METHODS: VAT and SAT density were determined from computed tomography scans in persons aged 65 and older, Health ABC (n = 2,735) and AGES-Reykjavik (n = 5,131), and 24 nonhuman primates (NHPs). Associations between adipose density and mortality (4-13 years follow-up) were assessed with Cox proportional hazards models. In NHPs, adipose density was related to serum markers and tissue characteristics. RESULTS: Higher density adipose tissue was associated with mortality in both studies with adjustment for risk factors including adipose area, total fat, and body mass index. In women, hazard ratio and 95% CI for the densest quintile (Q5) versus least dense (Q1) for VAT density were 1.95 (1.36-2.80; Health ABC) and 1.88 (1.31-2.69; AGES-Reykjavik) and for SAT density, 1.76 (1.35-2.28; Health ABC) and 1.56 (1.15-2.11; AGES-Reykjavik). In men, VAT density was associated with mortality in Health ABC, 1.52 (1.12-2.08), whereas SAT density was associated with mortality in both Health ABC, 1.58 (1.21-2.07), and AGES-Reykjavik, 1.43 (1.07-1.91). Higher density adipose tissue was associated with smaller adipocytes in NHPs. There were no consistent associations with inflammation in any group. Higher density adipose tissue was associated with lower serum leptin in Health ABC and NHPs, lower leptin mRNA expression in NHPs, and higher serum adiponectin in Health ABC and NHPs. CONCLUSION: VAT and SAT density provide a unique marker of mortality risk that does not appear to be inflammation related.
BACKGROUND: Knowledge of adipose composition in relation to mortality may help delineate inconsistent relationships between obesity and mortality in old age. We evaluated relationships between abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) density, mortality, biomarkers, and characteristics. METHODS: VAT and SAT density were determined from computed tomography scans in persons aged 65 and older, Health ABC (n = 2,735) and AGES-Reykjavik (n = 5,131), and 24 nonhuman primates (NHPs). Associations between adipose density and mortality (4-13 years follow-up) were assessed with Cox proportional hazards models. In NHPs, adipose density was related to serum markers and tissue characteristics. RESULTS: Higher density adipose tissue was associated with mortality in both studies with adjustment for risk factors including adipose area, total fat, and body mass index. In women, hazard ratio and 95% CI for the densest quintile (Q5) versus least dense (Q1) for VAT density were 1.95 (1.36-2.80; Health ABC) and 1.88 (1.31-2.69; AGES-Reykjavik) and for SAT density, 1.76 (1.35-2.28; Health ABC) and 1.56 (1.15-2.11; AGES-Reykjavik). In men, VAT density was associated with mortality in Health ABC, 1.52 (1.12-2.08), whereas SAT density was associated with mortality in both Health ABC, 1.58 (1.21-2.07), and AGES-Reykjavik, 1.43 (1.07-1.91). Higher density adipose tissue was associated with smaller adipocytes in NHPs. There were no consistent associations with inflammation in any group. Higher density adipose tissue was associated with lower serum leptin in Health ABC and NHPs, lower leptin mRNA expression in NHPs, and higher serum adiponectin in Health ABC and NHPs. CONCLUSION: VAT and SAT density provide a unique marker of mortality risk that does not appear to be inflammation related.
Authors: M Zamboni; G Mazzali; E Zoico; T B Harris; J B Meigs; V Di Francesco; F Fantin; L Bissoli; O Bosello Journal: Int J Obes (Lond) Date: 2005-09 Impact factor: 5.095
Authors: Marjolein Visser; Bret H Goodpaster; Stephen B Kritchevsky; Anne B Newman; Michael Nevitt; Susan M Rubin; Eleanor M Simonsick; Tamara B Harris Journal: J Gerontol A Biol Sci Med Sci Date: 2005-03 Impact factor: 6.053
Authors: P J Havel; S Kasim-Karakas; W Mueller; P R Johnson; R L Gingerich; J S Stern Journal: J Clin Endocrinol Metab Date: 1996-12 Impact factor: 5.958
Authors: Carol A Shively; Thomas C Register; David P Friedman; Timothy M Morgan; Jalonda Thompson; Tasha Lanier Journal: Biol Psychol Date: 2005-01-07 Impact factor: 3.251
Authors: R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer Journal: N Engl J Med Date: 1996-02-01 Impact factor: 91.245
Authors: Barbara J Nicklas; Matteo Cesari; Brenda W J H Penninx; Stephen B Kritchevsky; Jingzhong Ding; Anne Newman; Dalane W Kitzman; Alka M Kanaya; Marco Pahor; Tamara B Harris Journal: J Am Geriatr Soc Date: 2006-03 Impact factor: 5.562
Authors: Curtis Tilves; Joseph M Zmuda; Allison L Kuipers; J Jeffrey Carr; James G Terry; Victor Wheeler; Shyamal D Peddada; Sangeeta Nair; Iva Miljkovic Journal: Obesity (Silver Spring) Date: 2019-12-24 Impact factor: 5.002
Authors: Loïc Le Marchand; Lynne R Wilkens; Ann M Castelfranco; Kristine R Monroe; Bruce S Kristal; Iona Cheng; Gertraud Maskarinec; Meredith A Hullar; Johanna W Lampe; John A Shepherd; Adrian Franke; Thomas Ernst; Unhee Lim Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-03-04 Impact factor: 4.254
Authors: Samar R El Khoudary; Xirun Chen; Alexis Nasr; Kelly Shields; Emma Barinas-Mitchell; Imke Janssen; Susan A Everson-Rose; Lynda Powell; Karen Matthews Journal: J Gerontol A Biol Sci Med Sci Date: 2019-11-13 Impact factor: 6.053
Authors: Miriam A Bredella; Kalypso Karastergiou; Stijn A Bos; Anu V Gerweck; Martin Torriani; Susan K Fried; Karen K Miller Journal: Growth Horm IGF Res Date: 2017-06-12 Impact factor: 2.372
Authors: Paula Debroy; Jordan E Lake; Carlee Moser; Maxine Olefsky; Kristine M Erlandson; Ann Scherzinger; James H Stein; Judith S Currier; Todd T Brown; Grace A McComsey Journal: Clin Infect Dis Date: 2021-03-15 Impact factor: 9.079
Authors: Chris T Longenecker; Seunghee Margevicius; Yiying Liu; Mark D Schluchter; Chun-Ho Yun; Hiram G Bezerra; Grace A McComsey Journal: Am J Cardiol Date: 2017-07-24 Impact factor: 2.778
Authors: Rachel A Murphy; Steven Moore; Mary Playdon; Stephen Kritchevsky; Anne B Newman; Suzanne Satterfield; Hilsa Ayonayon; Clary Clish; Robert Gerszten; Tamara B Harris Journal: J Gerontol A Biol Sci Med Sci Date: 2019-01-01 Impact factor: 6.053
Authors: Rachel A Murphy; Ilse Reinders; Thomas C Register; Hilsa N Ayonayon; Anne B Newman; Suzanne Satterfield; Bret H Goodpaster; Eleanor M Simonsick; Stephen B Kritchevsky; Tamara B Harris Journal: Am J Clin Nutr Date: 2014-02-12 Impact factor: 7.045